Intramers as promising new tools in functional proteomics

Chemistry and Biology

Volumn 8, Issue 10, 2001, Pages 931-939

  Famulok, Michael ^a   Blind, Michael ^b   Mayer, Günter ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b NascaCell Technologies AG   (Germany)

Author keywords

Aptamer; Functional proteomics; Intracellular inhibitor; Intramer; Protein function characterization

Indexed keywords

EID: 0034802897     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(01)00070-9     Document Type: Article

References (67)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. The genome sequence of Drosophila melanogaster
4. Genome sequence of the nematode C. elegans: A platform for investigating biology
5. The complete genome sequence of Escherichia coli K-12
6. Life with 6000 genes
7. Genomics and medicine. Dissecting human disease in the postgenomic era
8. Proteomics in genomeland
9. Chemistry in biology: Life science's future
10. The yeast genome project: What did we learn?
11. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
12. Transcriptional activation by tetracyclines in mammalian cells
13. Tet B or not tet B: Advances in tetracycline-inducible gene expression
14. A good antisense molecule is hard to find
15. Ribozymes, genomics and therapeutics
16. Organic synthesis and biological signal transduction
17. Drug discovery. Integrating combinatorial synthesis and bioassays
18. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site
19. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries
20. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display
21. Intracellular antibodies: Development and therapeutic potential
22. Intrabody construction and expression. II. A synthetic catalytic Fv fragment
23. Intrabodies: Turning the humoral immune system outside in for intracellular immunization
24. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2
25. Green fluorescent protein as a scaffold for intracellular presentation of peptides
26. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold
27. Lipocalins as a scaffold
28. An artificial cell-cycle inhibitor isolated from a combinatorial library
29. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers
30. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase
31. In vitro evolution of functional nucleic acids: High-affinity RNA ligands of HIV-1 proteins
32. The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor
33. Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool
34. Selective optimization of the Rev-binding element of HIV-1
35. Selection and design of high-affinity RNA ligands for HIV-1 Rev
36. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo
37. Expression of small, therapeutic RNAs in human cell nuclei
38. Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs
39. Selective targeting and inhibition of yeast RNA polymerase II by RNA aptamers
40. RNA aptamers as effective protein antagonists in a multicellular organism
41. A specific RNA hairpin loop structure binds the RNA recognition motifs of the Drosophila SR protein B52
42. The inducible transcription activator NF-kappa B: Regulation by distinct protein subunits
43. Function and activation of NF-kappa B in the immune system
44. Nuclear factor kappa B, a mediator of lipopolysaccharide effects
45. Oxygen and the control of gene expression
46. Selection and characterization of an RNA decoy for transcription factor NF-kappa B
47. In vivo recognition of an RNA aptamer by its transcription factor target
48. A three-hybrid system to detect RNA-protein interactions in vivo
49. Cytoplasmic RNA-modulators of an inside-out signal transduction cascade
50. Ins and outs of LFA-1
51. Integrins and inside-out signal transduction: Converging signals from PKC and PIP3
52. Regulation of integrin function by inside-out signaling mechanisms
53. Poxvirus pathogenesis
54. Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5′ untranslated leader
55. Controlling small guanine-nucleotide-exchange factor function through cytoplasmic RNA intramers
56. Regulators and effectors of the ARF GTPases
57. Turning on ARF: The Sec7 family of guanine-nucleotide-exchange factors
58. Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1
59. Isozyme-specific inhibition of protein kinase C by RNA aptamers
60. RNA aptamers as pathway-specific MAP kinase inhibitors
61. Automated RNA selection
62. Controlled, targeted, intracellular expression of ribozymes: Progress and problems
63. Designing Ribozymes for the inhibition of gene expression
64. Anti-idiotype RNA selected with an anti-nuclear export signal antibody is actively transported in oocytes and inhibits Rev- and cap-dependent RNA export
65. Anti-idiotype RNAs that mimic the leucine-rich nuclear export signal and specifically bind to CRM1/exportin 1
66. Selection and nuclear immobilization of exportable RNAs
67. In vivo selection of RNAs that localize in the nucleus